| Recruiting | 2 | 300 | US, RoW | Upamostat, WX-671, RHB-107, Placebo (PO) | Henry M. Jackson Foundation for the Advancement of Military Medicine, Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies, RedHill Biopharma Limited, FHI Clinical, Inc. | SARS-CoV-2 | 03/25 | 10/25 | | |
NCT04595968: Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus |
|
|
| Completed | N/A | 267 | Europe, US | Vestal DM Active device, Lifestyle modification, Vestal DM Sham device | Neurovalens Ltd., University College Dublin, CS Lifescience, Clinical Trial Mentors | Type 2 Diabetes | 08/24 | 08/24 | | |
